T1210
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T1210, covering 2012-04-12 to 2012-04-12. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis [Phase 2]